High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2)

Biochemical Journal

Volumn 389, Issue 1, 2005, Pages 91-97

  Battista, Sabrina ^a   Fedele, Monica ^a   Hoyos, Josefina Martinez ^a   Pentimalli, Francesca ^a   Pierantoni, Giovanna Maria ^a   Visone, Rosa ^a   De Martino, Ivana ^a   Croce, Carlo Maria ^b   Fusco, Alfredo ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Electrophoretic mobility shift assay (EMSA); Embryonic stem cell; High mobility group A1 (HMGA1); Lymphopoiesis; MEF; Recombination activating gene 2 (RAG2)

Indexed keywords

BIOLOGICAL ORGANS; CELLS; GENES; IMMUNOLOGY; TUMORS;

EMBRYOGENESIS; HIGH-MOBILITY-GROUP A1 (HMGA1) PROTEINS; LYMPHOPOIESIS; TRANSCRIPTION FACTORS;

PROTEINS;

HIGH MOBILITY GROUP A PROTEIN; RAG2 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION; YOLK SAC;

ANIMALS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HMGA PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; STEM CELLS; UP-REGULATION; YOLK SAC;

EID: 22144484804     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20041607     Document Type: Article

References (31)

1. Fedele, M., Battista, S., Manfioletti, G., Croce, C. M., Giancotti, V. and Fusco, A. (2001) Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22, 1583-1591
2. Battista, S., Pentimalli, F., Baldassarre, G., Fedele, M., Fidanza, V., Croce, C. M. and Fusco, A. (2003) Loss of hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. FASEB J. 17, 1496-1498
3. Weaver, D. T. (1995) V(D)J recombination and double-strand break repair. Adv. Immunol. 58, 29-85
4. Fugmann, S. D., Lee, A. I., Shockett, P. E., Villey, I. J. and Schatz, D. G. (2000) The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18, 495-527
5. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M. et al. (1992) RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangment. Cell (Cambridge, Mass.) 68, 855-867
6. Schwarz, K., Gauss, G. H., Ludwig, L., Pannicke, U., Li, Z., Lindner, D., Friedrich, W., Seger, R. A., Hansen-Hagge, T. E., Desiderio, S. et al. (1996) RAG mutations in human B cell-negative SCID. Science 274, 97-99
7. Villa, A., Santagata, S., Bozzi, F., Giliani, S., Frattini, A., Imberti, L., Gatta, L., Ochs, H., Schwarz, K., Notarangelo, L. D. et al. (1998) Partial V(D)J recombination activity leads to Omen syndrome. Cell (Cambridge, Mass.) 98, 885-896
8. Kishi, H., Wei, X.-C., Jin, Z.-X., Fujishiro, Y., Nagata, T., Matsuda, T. and Muraguchi, A. (2000) Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells. Blood 95, 3845-3852
9. Jin, Z. X., Kishi, H., Wei, X. C., Matsuda, T., Saito, S. and Muraguchi, A. (2002) Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells. J. Immunol. 169, 3783-3792
10. Kitagawa, T., Mori, K., Kishi, H., Tagoh, H., Nagata, T., Kurioka, H. and Muraguchi, A. (1996) Chromatin structure and transcriptional regulation of human RAG-1 gene. Blood 88, 3785-3791
11. Wei, X. C., Kishi, H., Jin, Z. X., Zhao, W. P., Kondo, S., Matsuda, T., Saito, S. and Muraguchi, A. (2002) Characterization of chromatin structure and enhancer elements for murine recombination activating gene-2. J. Immunol. 169, 873-871
12. Lauring, J. and Schlissel, M. S. (1999) Distinct factors regulate the murine RAG2 promoter in B- and T-cell lines. Mol. Cell. Biol. 19, 2601-2612
13. Zarrin, A., Fong, I., Malkin, L., Marsden, P. and Berinstein, N. (1997) Cloning and characterization of the human recombination activating gene 1 (RAG1) and RAG2 promoter regions. J. Immunol. 159, 4382-4394
14. Wang, Q.-F., Lauring, J. and Schlissel, M. (2000) c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineages. Mol. Cell. Biol. 20, 9203-9211
15. Battista, S., Fidanza, V., Fedele, M., Klein-Szanto, J. P., Outwater, E., Brunner, H., Santoro, M., Croce, C. M. and Fusco, A. (1999) The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res. 59, 4793-4797
16. Potocnik, A. J., Nielsen, P. J. and Eichmann, K. (1994) In vitro generation of lymphoid precursors from embryonic stem cells. EMBO J. 13, 5274-5283
17. Melillo, R. M., Pierantoni, G. M., Scala, S., Stella, A., Battista, S., De Biasio, M. C., Fedele, M., Chiappetta, G., Fidanza, V., Condorelli, G. et al. (2001) Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol. Cell. Biol. 21, 2485-2495
18. Baldassarre, G., Fedele, M., Battista, S., Vecchione, A., Klein-Szanto, A. J., Santoro, M., Waldmann, T. A., Azimi, N., Croce, C. M. and Fusco, A. (2001) Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. U.S.A. 98, 7970-7975
19. Thanos, D. and Maniatis, T. (1995) Virus induction of human IFN β gene expression requires the assembly of an enhanceosome. Cell (Cambridge, Mass.) 83, 1091-1100
20. Baldassarre, G., Battista, S., Thakur, S., Belletti, B., Pentimalli, F., Trapasso, F., Fedele, M., Pierantoni, M. G., Croce, C. M. and Fusco, A. (2003) Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol. Cell. Biol. 23, 2225-2238
21. Chiappetta, G., Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V. and Fusco, A. (1995) The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene 10, 1307-1314
22. Fong, I. C., Zarrin, A. A., Wu, G. E. and Berinstein, N. L. (2000) Functional analysis of the human RAG2 promoter. Mol. Immunol. 37, 391-402
23. John, S., Reeves, R., Lin, J., Child, R., Leiden, J. M., Thompson, C. B. and Leonard, W. J. (1995) Regulation of cell-type-specific interleukin-2 receptor-chain gene expression: potential role of physical interaction between Elf-1, HMG-I(Y), and NF-B family proteins. Mol. Cell. Biol. 15, 1786-1796
24. Yie, J., Liang, S., Merika, M. and Thanos, D. (1997) Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter. Mol. Cell. Biol. 17, 3649-3662
25. Hiom, K., Melek, M. and Gellert, M. (1998) DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocation. Cell (Cambridge, Mass.) 94, 463-470
26. Baldassarre, G., Belletti, B., Battista, S., Nicoloso, M. S., Pentimalli, F., Fedele, M., Croce, C. M. and Fusco, A. (2005) HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. Oncogene, in the press
27. Zlatanova, J. and van Holde, K. (1998) Binding to four-way junction DNA: a common property of architectural proteins? FASEB J. 12, 421-431
28. Hill, D. A., Pedulla, M. L. and Reeves, R. (1999) Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1. Nucleic Acids Res. 27, 2135-2144
29. Varga-Weisz, P., von Holde and Zatlanova, J. (1994) Competition between linker histones and HMG1 for binding to four-way junction DNA: implications for transcription. Biochem. Biophys. Res. Commun. 203, 1904-1911
30. Wada, T., Takei, K., Kudo, M., Shimura, S., Kasahara, Y., Koizumi, S., Kawa-Ha, K., Ishida, Y., Imashuku, S., Seki, H. et al. (2000) Characterization of immune function and analysis of RAG gene mutations in Omen syndrome and related disorders. Clin. Exp. Immunol. 119, 148-155
31. Abe, T., Tsuge, I., Kamachi, Y., Torii, S., Utsumi, K., Akahori, Y., Ichihara, Y., Kurosawa, Y. and Matsuoka, H. (1994) Evidence for defects in V(D)J rearrangements in patients with severe combined immunodeficiency. J. Immunol. 152, 5504-5513